{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:31:54Z","timestamp":1774395114989,"version":"3.50.1"},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1001\/jamasurg.2019.1171","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T11:33:23Z","timestamp":1559129603000},"page":"715","source":"Crossref","is-referenced-by-count":7,"title":["Adjuvant Therapy for Ampullary Cancer"],"prefix":"10.1001","volume":"154","author":[{"given":"Andrew H.","family":"Ko","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, University of California, San Francisco"},{"name":"UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric K.","family":"Nakakura","sequence":"additional","affiliation":[{"name":"UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco"},{"name":"Division of General Surgery, Section of Surgical Oncology and Hepatopancreaticobiliary Surgery, Department of Surgery, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"25","key":"sic190022r1","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer.","volume":"379","author":"Conroy","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"sic190022r2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jama.2012.7352","article-title":"Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.","volume":"308","author":"Neoptolemos","year":"2012","journal-title":"JAMA"},{"key":"sic190022r3","article-title":"Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline","author":"Shroff","journal-title":"J Clin Oncol"},{"issue":"8","key":"sic190022r4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study.","volume":"37","author":"Edeline","year":"2019","journal-title":"J Clin Oncol"},{"key":"sic190022r5","article-title":"Role of adjuvant multimodality therapy after curative-intent resection of ampullary carcinoma","author":"Ecker","journal-title":"JAMA Surg"},{"key":"sic190022r6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/s12885-016-2677-3","article-title":"Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma.","volume":"16","author":"Overman","year":"2016","journal-title":"BMC Cancer"},{"key":"sic190022r7","article-title":"Ampullary cancer: evaluation of somatic and germline genetic alterations and association with clinical outcomes","author":"Wong","journal-title":"Cancer"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/article-pdf\/154\/8\/715\/17824115\/jamasurgery_ko_2019_ic_190022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T11:14:40Z","timestamp":1566386080000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2734846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":7,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2019.1171","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}